These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18327728)

  • 1. Assessing learning effects and nonrandom dropout in a contraceptive device trial.
    Chen PL
    J Biopharm Stat; 2008; 18(2):382-92. PubMed ID: 18327728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accounting for dropout bias using mixed-effects models.
    Mallinckrodt CH; Clark WS; David SR
    J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A local sensitivity analysis approach to longitudinal non-Gaussian data with non-ignorable dropout.
    Xie H
    Stat Med; 2008 Jul; 27(16):3155-77. PubMed ID: 17948917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival analysis of dropout patterns in dieting clinical trials.
    Landers PS; Landers TL
    J Am Diet Assoc; 2004 Oct; 104(10):1586-8. PubMed ID: 15389418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity analysis of longitudinal normal data with drop-outs.
    Minini P; Chavance M
    Stat Med; 2004 Apr; 23(7):1039-54. PubMed ID: 15057877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias reduction with an adjustment for participants' intent to dropout of a randomized controlled clinical trial.
    Leon AC; Demirtas H; Hedeker D
    Clin Trials; 2007; 4(5):540-7. PubMed ID: 17942469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hybrid model for nonignorable dropout in longitudinal binary responses.
    Wilkins KJ; Fitzmaurice GM
    Biometrics; 2006 Mar; 62(1):168-76. PubMed ID: 16542243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dropout on the efficiency of D-optimal designs of linear mixed models.
    Ortega-Azurduy SA; Tan FE; Berger MP
    Stat Med; 2008 Jun; 27(14):2601-17. PubMed ID: 17943923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impact of attrition in randomized controlled trials.
    Hewitt CE; Kumaravel B; Dumville JC; Torgerson DJ;
    J Clin Epidemiol; 2010 Nov; 63(11):1264-70. PubMed ID: 20573482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intent-to-treat analysis for longitudinal studies with drop-outs.
    Little R; Yau L
    Biometrics; 1996 Dec; 52(4):1324-33. PubMed ID: 8962456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dropouts in longitudinal studies: definitions and models.
    Lindsey JK
    J Biopharm Stat; 2000 Nov; 10(4):503-25. PubMed ID: 11104390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating and comparing correct-use failure probabilities in clinical studies of condom functionality.
    Weaver MA; Taylor DJ; Dominik RC
    J Biopharm Stat; 2003 Aug; 13(3):549-64. PubMed ID: 12921401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginalized transition models for longitudinal binary data with ignorable and non-ignorable drop-out.
    Kurland BF; Heagerty PJ
    Stat Med; 2004 Sep; 23(17):2673-95. PubMed ID: 15316952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
    Salim A; Mackinnon A; Griffiths K
    Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian sensitivity model for intention-to-treat analysis on binary outcomes with dropouts.
    Kaciroti NA; Schork MA; Raghunathan T; Julius S
    Stat Med; 2009 Feb; 28(4):572-85. PubMed ID: 19072769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting sexually transmissible infection prevention trials by adjusting for the magnitude of exposure.
    Wilson DP
    Clin Trials; 2010 Feb; 7(1):36-43. PubMed ID: 20007407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
    Siddiqui O; Ali MW
    J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.